Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level
- PMID: 2648923
- DOI: 10.7326/0003-4819-110-8-622
Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level
Abstract
From our review of the epidemiologic and clinical literature, we have developed recommendations for using the serum cholesterol test as a component of strategies to prevent coronary heart disease in asymptomatic adults. Total cholesterol, high-density lipoprotein, and low-density lipoprotein levels are risk factors for coronary disease and early mortality in middle-aged men. Weaker evidence suggests that hypercholesterolemia increases the risk for coronary disease in women or elderly men, or that hypertriglyceridemia increases the risk in men or women. A reduction in cholesterol levels lowers the incidence of and the mortality from coronary disease in asymptomatic, hypercholesterolemic, middle-aged men, but has not been shown to reduce overall mortality. The efficacy of treatment in women and elderly persons has not been studied. Screening and treatment plans should be individualized; a 5-year period between tests is adequate for asymptomatic, low-risk men, whereas more frequent testing is appropriate for high-risk men. Screening is optional for women and elderly persons.
Comment in
-
Cholesterol and screening of asymptomatic adults.Ann Intern Med. 1990 Mar 1;112(5):384-5. doi: 10.7326/0003-4819-112-5-384. Ann Intern Med. 1990. PMID: 2353953 No abstract available.
-
Cholesterol screening and coronary artery heart disease.Ann Intern Med. 1989 Aug 15;111(4):341-2. doi: 10.7326/0003-4819-111-4-341. Ann Intern Med. 1989. PMID: 2757317 No abstract available.
Similar articles
-
Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo Study.Ann Epidemiol. 1992 Jan-Mar;2(1-2):77-83. doi: 10.1016/1047-2797(92)90040-w. Ann Epidemiol. 1992. PMID: 1342268
-
Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.J Am Board Fam Pract. 1991 Sep-Oct;4(5):285-97. J Am Board Fam Pract. 1991. PMID: 1746296 Clinical Trial.
-
Prevention of coronary heart disease through cholesterol reduction.Am Fam Physician. 1997 May 1;55(6):2250-8. Am Fam Physician. 1997. PMID: 9149652 Review.
-
[Statins in primary prevention of coronary heart disease].Wien Med Wochenschr. 1999;149(5-6):129-38. Wien Med Wochenschr. 1999. PMID: 10408004 Review. German.
-
Hypercholesterolemia in elderly persons: resolving the treatment dilemma.Ann Intern Med. 1990 May 15;112(10):780-92. doi: 10.7326/0003-4819-112-10-780. Ann Intern Med. 1990. PMID: 2184712 Review.
Cited by
-
The yield of cholesterol screening in an urban black community.Am J Public Health. 1991 Apr;81(4):448-51. doi: 10.2105/ajph.81.4.448. Am J Public Health. 1991. PMID: 2003622 Free PMC article.
-
Cholesterol-lowering therapy: what patients expect in return.J Gen Intern Med. 1993 Nov;8(11):591-6. doi: 10.1007/BF02599710. J Gen Intern Med. 1993. PMID: 8289097
-
Asymptomatic hypertriglyceridaemia.BMJ. 1992 Feb 15;304(6824):394-6. doi: 10.1136/bmj.304.6824.394. BMJ. 1992. PMID: 1547385 Free PMC article. No abstract available.
-
The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects.Clin Transl Sci. 2019 Nov;12(6):704-712. doi: 10.1111/cts.12677. Epub 2019 Sep 26. Clin Transl Sci. 2019. PMID: 31365188 Free PMC article. Clinical Trial.
-
Radiographically detectable calcium and atherosclerosis: the connection and its exploitation.Int J Card Imaging. 1992;8(3):209-15. doi: 10.1007/BF01146839. Int J Card Imaging. 1992. PMID: 1527443 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical